Directorate change

AI SummaryClose X

SkinBioTherapeutics plc has announced directorate changes effective January 1, 2026, appointing Alyson Levett as a non-executive director and Chair of the Audit Committee, and promoting Emily Bertram to Chief Financial Officer and an executive director. Danielle Bekker has stepped down from the Board but will remain as an external advisor. Alyson Levett brings over 20 years of C-suite financial experience and expertise with AIM companies, while Emily Bertram is a qualified Chartered Accountant with extensive experience in finance roles across various industries. These appointments are intended to strengthen the Board's financial expertise and support executive management.

Disclaimer*

UK 100

Latest directors dealings